Skip to main content
PMC home page
Molecular and Cellular Biology logoLink to Molecular and Cellular Biology
. 1997 Mar;17(3):1236–1243. doi: 10.1128/mcb.17.3.1236

Physical and functional interaction between the human T-cell lymphotropic virus type 1 Tax1 protein and the CCAAT binding protein NF-Y.

C A Pise-Masison 1, J Dittmer 1, K E Clemens 1, J N Brady 1
PMCID: PMC231848  PMID: 9032250

Abstract

Tax1, a potent activator of human T-cell lymphotropic virus type 1 (HTLV-1) transcription, has been shown to modulate expression of many cellular genes. Tax1 does not bind DNA directly but regulates transcription through protein-protein interactions with sequence-specific transcription factors. Using the yeast two-hybrid system to screen for proteins which interact with Tax1, we isolated the B subunit of the CCAAT binding protein NF-Y from a HeLa cDNA library. The interaction of Tax1 with NF-YB was specific in that NF-YB did not interact with a variety of other transcription factors, including human immunodeficiency virus Tat, human papillomavirus E6, and Bicoid, or with the M7 (amino acids 29CP-AS) Tax1 mutant. However, NF-YB did interact with the C-terminal Tax1 mutants M22 (130TL-AS) and M47 (319LL-RS). We also show that in vitro-translated NF-YB specifically bound to a glutathione S-transferase-Tax1 fusion protein. Further, Tax1 coimmunoprecipitated with NF-Y from nuclear extracts of HTLV-1-transformed cells, providing evidence for in vivo interaction of Tax1 and NF-YB. We further demonstrate that Tax1 specifically activated the NF-Y-responsive DQbeta promoter, as well as a minimal promoter which contains only the Y-box element. In addition, mutation of the Y-box element alone abrogated Tax1-mediated activation. Taken together, these data indicate that Tax1 interacts with NF-Y through the B subunit and that this interaction results in activation of the major histocompatibility complex class II promoter. Through activation of this and other NF-Y driven promoters, the Tax1-NF-Y interaction may play a critical role in causing cellular transformation and HTLV-1 pathogenesis.

Full Text

The Full Text of this article is available as a PDF (240.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adya N., Zhao L. J., Huang W., Boros I., Giam C. Z. Expansion of CREB's DNA recognition specificity by Tax results from interaction with Ala-Ala-Arg at positions 282-284 near the conserved DNA-binding domain of CREB. Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5642–5646. doi: 10.1073/pnas.91.12.5642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Agoff S. N., Hou J., Linzer D. I., Wu B. Regulation of the human hsp70 promoter by p53. Science. 1993 Jan 1;259(5091):84–87. doi: 10.1126/science.8418500. [DOI] [PubMed] [Google Scholar]
  3. Akari H., Goto Y., Shinjo T. Detection of the cellular membrane proteins on human T cell leukemia virus type I. Arch Virol. 1995;140(2):375–382. doi: 10.1007/BF01309871. [DOI] [PubMed] [Google Scholar]
  4. Anderson M. G., Dynan W. S. Quantitative studies of the effect of HTLV-I Tax protein on CREB protein--DNA binding. Nucleic Acids Res. 1994 Aug 11;22(15):3194–3201. doi: 10.1093/nar/22.15.3194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Armstrong A. P., Franklin A. A., Uittenbogaard M. N., Giebler H. A., Nyborg J. K. Pleiotropic effect of the human T-cell leukemia virus Tax protein on the DNA binding activity of eukaryotic transcription factors. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7303–7307. doi: 10.1073/pnas.90.15.7303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Baranger A. M., Palmer C. R., Hamm M. K., Giebler H. A., Brauweiler A., Nyborg J. K., Schepartz A. Mechanism of DNA-binding enhancement by the human T-cell leukaemia virus transactivator Tax. Nature. 1995 Aug 17;376(6541):606–608. doi: 10.1038/376606a0. [DOI] [PubMed] [Google Scholar]
  7. Baxevanis A. D., Arents G., Moudrianakis E. N., Landsman D. A variety of DNA-binding and multimeric proteins contain the histone fold motif. Nucleic Acids Res. 1995 Jul 25;23(14):2685–2691. doi: 10.1093/nar/23.14.2685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Boulikas T. Nuclear localization signals (NLS). Crit Rev Eukaryot Gene Expr. 1993;3(3):193–227. [PubMed] [Google Scholar]
  9. Brauweiler A., Garl P., Franklin A. A., Giebler H. A., Nyborg J. K. A molecular mechanism for human T-cell leukemia virus latency and Tax transactivation. J Biol Chem. 1995 May 26;270(21):12814–12822. doi: 10.1074/jbc.270.21.12814. [DOI] [PubMed] [Google Scholar]
  10. Brodsky F. M., Guagliardi L. E. The cell biology of antigen processing and presentation. Annu Rev Immunol. 1991;9:707–744. doi: 10.1146/annurev.iy.09.040191.003423. [DOI] [PubMed] [Google Scholar]
  11. Brown K., Park S., Kanno T., Franzoso G., Siebenlist U. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2532–2536. doi: 10.1073/pnas.90.6.2532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bryans M., Lucas J. M., Knobloch T. J., Wilkie N. M., Lang J. C. Regulation of FGF-4 enhancer activity by transcription factor NF-Y. Biochem Biophys Res Commun. 1995 Jun 15;211(2):519–527. doi: 10.1006/bbrc.1995.1844. [DOI] [PubMed] [Google Scholar]
  13. Chang Z. F., Liu C. J. Human thymidine kinase CCAAT-binding protein is NF-Y, whose A subunit expression is serum-dependent in human IMR-90 diploid fibroblasts. J Biol Chem. 1994 Jul 8;269(27):17893–17898. [PubMed] [Google Scholar]
  14. Chen H., Campisi J., Padmanabhan R. SV40 large T antigen transactivates the human cdc2 promoter by inducing a CCAAT box binding factor. J Biol Chem. 1996 Jun 14;271(24):13959–13967. [PubMed] [Google Scholar]
  15. Clemens K. E., Piras G., Radonovich M. F., Choi K. S., Duvall J. F., DeJong J., Roeder R., Brady J. N. Interaction of the human T-cell lymphotropic virus type 1 tax transactivator with transcription factor IIA. Mol Cell Biol. 1996 Sep;16(9):4656–4664. doi: 10.1128/mcb.16.9.4656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cogswell J. P., Zeleznik-Le N., Ting J. P. Transcriptional regulation of the HLA-DRA gene. Crit Rev Immunol. 1991;11(2):87–112. [PubMed] [Google Scholar]
  17. Daenke S., Nightingale S., Cruickshank J. K., Bangham C. R. Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J Virol. 1990 Mar;64(3):1278–1282. doi: 10.1128/jvi.64.3.1278-1282.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dittmer J., Gitlin S. D., Reid R. L., Brady J. N. Transactivation of the P2 promoter of parathyroid hormone-related protein by human T-cell lymphotropic virus type I Tax1: evidence for the involvement of transcription factor Ets1. J Virol. 1993 Oct;67(10):6087–6095. doi: 10.1128/jvi.67.10.6087-6095.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Dorn A., Bollekens J., Staub A., Benoist C., Mathis D. A multiplicity of CCAAT box-binding proteins. Cell. 1987 Sep 11;50(6):863–872. doi: 10.1016/0092-8674(87)90513-7. [DOI] [PubMed] [Google Scholar]
  20. Filatov D., Thelander L. Role of a proximal NF-Y binding promoter element in S phase-specific expression of mouse ribonucleotide reductase R2 gene. J Biol Chem. 1995 Oct 20;270(42):25239–25243. doi: 10.1074/jbc.270.42.25239. [DOI] [PubMed] [Google Scholar]
  21. Franchini G. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood. 1995 Nov 15;86(10):3619–3639. [PubMed] [Google Scholar]
  22. Franklin A. A., Kubik M. F., Uittenbogaard M. N., Brauweiler A., Utaisincharoen P., Matthews M. A., Dynan W. S., Hoeffler J. P., Nyborg J. K. Transactivation by the human T-cell leukemia virus Tax protein is mediated through enhanced binding of activating transcription factor-2 (ATF-2) ATF-2 response and cAMP element-binding protein (CREB). J Biol Chem. 1993 Oct 5;268(28):21225–21231. [PubMed] [Google Scholar]
  23. Franklin A.A., Nyborg J.K. Mechanisms of Tax Regulation of Human T Cell Leukemia Virus Type I Gene Expression. J Biomed Sci. 1995 Jan;2(1):17–29. doi: 10.1007/BF02257921. [DOI] [PubMed] [Google Scholar]
  24. Fukushima A., Ueno H. The relationship between HTLV-I-infected cell lines and uveitis. Graefes Arch Clin Exp Ophthalmol. 1995 Apr;233(4):231–235. doi: 10.1007/BF00183597. [DOI] [PubMed] [Google Scholar]
  25. Gazzolo L., Duc Dodon M. Direct activation of resting T lymphocytes by human T-lymphotropic virus type I. Nature. 1987 Apr 16;326(6114):714–717. doi: 10.1038/326714a0. [DOI] [PubMed] [Google Scholar]
  26. Gessain A., Saal F., Gout O., Daniel M. T., Flandrin G., de The G., Peries J., Sigaux F. High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. Blood. 1990 Jan 15;75(2):428–433. [PubMed] [Google Scholar]
  27. Grassmann R., Berchtold S., Radant I., Alt M., Fleckenstein B., Sodroski J. G., Haseltine W. A., Ramstedt U. Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J Virol. 1992 Jul;66(7):4570–4575. doi: 10.1128/jvi.66.7.4570-4575.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Grassmann R., Dengler C., Müller-Fleckenstein I., Fleckenstein B., McGuire K., Dokhelar M. C., Sodroski J. G., Haseltine W. A. Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. Proc Natl Acad Sci U S A. 1989 May;86(9):3351–3355. doi: 10.1073/pnas.86.9.3351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Gregersen P. K. HLA class II polymorphism: implications for genetic susceptibility to autoimmune disease. Lab Invest. 1989 Jul;61(1):5–19. [PubMed] [Google Scholar]
  30. Hall W. W., Liu C. R., Schneewind O., Takahashi H., Kaplan M. H., Röupe G., Vahlne A. Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides. Science. 1991 Jul 19;253(5017):317–320. doi: 10.1126/science.1857968. [DOI] [PubMed] [Google Scholar]
  31. Hasan S., Koda T., Kakinuma M. An upstream NF-Y-binding site is required for transcriptional activation from the hst promoter in F9 embryonal carcinoma cells. J Biol Chem. 1994 Oct 7;269(40):25042–25048. [PubMed] [Google Scholar]
  32. Hasunuma T., Nakajima T., Aono H., Sato K., Matsubara T., Yamamoto K., Nishioka K. Establishment and characterization of synovial cell clones with integrated human T-cell leukemia virus type-I. Clin Immunol Immunopathol. 1994 Jul;72(1):90–97. doi: 10.1006/clin.1994.1111. [DOI] [PubMed] [Google Scholar]
  33. Hinrichs S. H., Nerenberg M., Reynolds R. K., Khoury G., Jay G. A transgenic mouse model for human neurofibromatosis. Science. 1987 Sep 11;237(4820):1340–1343. doi: 10.1126/science.2888191. [DOI] [PubMed] [Google Scholar]
  34. Hirai H., Suzuki T., Fujisawa J., Inoue J., Yoshida M. Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor kappa B and induces nuclear translocation of transcription factor NF-kappa B proteins for transcriptional activation. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3584–3588. doi: 10.1073/pnas.91.9.3584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Hiscott J., Petropoulos L., Lacoste J. Molecular interactions between HTLV-1 Tax protein and the NF-kappa B/kappa B transcription complex. Virology. 1995 Dec 1;214(1):3–11. doi: 10.1006/viro.1995.9960. [DOI] [PubMed] [Google Scholar]
  36. Ito H., Fukuda Y., Murata K., Kimura A. Transformation of intact yeast cells treated with alkali cations. J Bacteriol. 1983 Jan;153(1):163–168. doi: 10.1128/jb.153.1.163-168.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Iwakura Y., Saijo S., Kioka Y., Nakayama-Yamada J., Itagaki K., Tosu M., Asano M., Kanai Y., Kakimoto K. Autoimmunity induction by human T cell leukemia virus type 1 in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans. J Immunol. 1995 Aug 1;155(3):1588–1598. [PubMed] [Google Scholar]
  38. Jacobson S., Reuben J. S., Streilein R. D., Palker T. J. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1. J Immunol. 1991 Feb 15;146(4):1155–1162. [PubMed] [Google Scholar]
  39. Jacobson S., Shida H., McFarlin D. E., Fauci A. S., Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature. 1990 Nov 15;348(6298):245–248. doi: 10.1038/348245a0. [DOI] [PubMed] [Google Scholar]
  40. Kannagi M., Matsushita S., Shida H., Harada S. Cytotoxic T cell response and expression of the target antigen in HTLV-I infection. Leukemia. 1994 Apr;8 (Suppl 1):S54–S59. [PubMed] [Google Scholar]
  41. Kanno T., Brown K., Franzoso G., Siebenlist U. Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-kappa B. Mol Cell Biol. 1994 Oct;14(10):6443–6451. doi: 10.1128/mcb.14.10.6443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Kimata J. T., Ratner L. Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization. J Virol. 1991 Aug;65(8):4398–4407. doi: 10.1128/jvi.65.8.4398-4407.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Kinoshita T., Tsujimoto A., Shimotohno K. Sequence variations in LTR and env regions of HTLV-I do not discriminate between the virus from patients with HTLV-I-associated myelopathy and adult T-cell leukemia. Int J Cancer. 1991 Feb 20;47(4):491–495. doi: 10.1002/ijc.2910470403. [DOI] [PubMed] [Google Scholar]
  44. Kira J., Itoyama Y., Koyanagi Y., Tateishi J., Kishikawa M., Akizuki S., Kobayashi I., Toki N., Sueishi K., Sato H. Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy. Ann Neurol. 1992 Jan;31(1):39–45. doi: 10.1002/ana.410310108. [DOI] [PubMed] [Google Scholar]
  45. LaGrenade L., Hanchard B., Fletcher V., Cranston B., Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet. 1990 Dec 1;336(8727):1345–1347. doi: 10.1016/0140-6736(90)92896-p. [DOI] [PubMed] [Google Scholar]
  46. Lehky T. J., Cowan E. P., Lampson L. A., Jacobson S. Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells. J Virol. 1994 Mar;68(3):1854–1863. doi: 10.1128/jvi.68.3.1854-1863.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Li-Weber M., Davydov I. V., Krafft H., Krammer P. H. The role of NF-Y and IRF-2 in the regulation of human IL-4 gene expression. J Immunol. 1994 Nov 1;153(9):4122–4133. [PubMed] [Google Scholar]
  48. Luckow B., Schütz G. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 1987 Jul 10;15(13):5490–5490. doi: 10.1093/nar/15.13.5490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Mach B. MHC class II regulation--lessons from a disease. N Engl J Med. 1995 Jan 12;332(2):120–122. doi: 10.1056/NEJM199501123320211. [DOI] [PubMed] [Google Scholar]
  50. Maity S. N., Sinha S., Ruteshouser E. C., de Crombrugghe B. Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor. J Biol Chem. 1992 Aug 15;267(23):16574–16580. [PubMed] [Google Scholar]
  51. Mann D. L., DeSantis P., Mark G., Pfeifer A., Newman M., Gibbs N., Popovic M., Sarngadharan M. G., Gallo R. C., Clark J. HTLV-I--associated B-cell CLL: indirect role for retrovirus in leukemogenesis. Science. 1987 May 29;236(4805):1103–1106. doi: 10.1126/science.2883731. [DOI] [PubMed] [Google Scholar]
  52. Marcil R., Higgins D. R. Direct transfer of plasmid DNA from yeast to E.coli by electroporation. Nucleic Acids Res. 1992 Feb 25;20(4):917–917. doi: 10.1093/nar/20.4.917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Matsuzaki Y., Fujisawa J., Yoshida M. Identification of transcriptional activation domain of TREB5, a CREB/ATF family protein that binds to HTLV-1 enhancer. J Biochem. 1995 Feb;117(2):303–308. doi: 10.1093/jb/117.2.303. [DOI] [PubMed] [Google Scholar]
  54. Matthews M. A., Markowitz R. B., Dynan W. S. In vitro activation of transcription by the human T-cell leukemia virus type I Tax protein. Mol Cell Biol. 1992 May;12(5):1986–1996. doi: 10.1128/mcb.12.5.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. McKinsey T. A., Brockman J. A., Scherer D. C., Al-Murrani S. W., Green P. L., Ballard D. W. Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB. Mol Cell Biol. 1996 May;16(5):2083–2090. doi: 10.1128/mcb.16.5.2083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Monaco J. J. Structure and function of genes in the MHC class II region. Curr Opin Immunol. 1993 Feb;5(1):17–20. doi: 10.1016/0952-7915(93)90075-4. [DOI] [PubMed] [Google Scholar]
  57. Mori M., Ban N., Kinoshita K. Familial occurrence of HTLV-I--associated myelopathy. Ann Neurol. 1988 Jan;23(1):100–100. doi: 10.1002/ana.410230119. [DOI] [PubMed] [Google Scholar]
  58. Mukhopadhyaya R., Sadaie M. R. Nucleotide sequence analysis of HTLV-I isolated from cerebrospinal fluid of a patient with TSP/HAM: comparison to other HTLV-I isolates. AIDS Res Hum Retroviruses. 1993 Feb;9(2):109–114. doi: 10.1089/aid.1993.9.109. [DOI] [PubMed] [Google Scholar]
  59. Munoz E., Israël A. Activation of NF-kappa B by the Tax protein of HTLV-1. Immunobiology. 1995 Jul;193(2-4):128–136. doi: 10.1016/s0171-2985(11)80535-8. [DOI] [PubMed] [Google Scholar]
  60. Nerenberg M., Hinrichs S. H., Reynolds R. K., Khoury G., Jay G. The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science. 1987 Sep 11;237(4820):1324–1329. doi: 10.1126/science.2888190. [DOI] [PubMed] [Google Scholar]
  61. Nishioka K., Maruyama I., Sato K., Kitajima I., Nakajima Y., Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet. 1989 Feb 25;1(8635):441–441. doi: 10.1016/s0140-6736(89)90038-x. [DOI] [PubMed] [Google Scholar]
  62. Noraz N., Verrier B., Fraisier C., Desgranges C. Cell surface phenotypic changes induced in H9 T cells chronically infected with HTLV type I or HIV type 1 or coinfected with the two viruses. AIDS Res Hum Retroviruses. 1995 Jan;11(1):145–154. doi: 10.1089/aid.1995.11.145. [DOI] [PubMed] [Google Scholar]
  63. Ohshima K., Kikuchi M., Masuda Y., Sumiyoshi Y., Eguchi F., Mohtai H., Takeshita M., Kimura N. Human T-cell leukemia virus type I associated lymphadenitis. Cancer. 1992 Jan 1;69(1):239–248. doi: 10.1002/1097-0142(19920101)69:1<239::aid-cncr2820690139>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  64. Paca-Uccaralertkun S., Zhao L. J., Adya N., Cross J. V., Cullen B. R., Boros I. M., Giam C. Z. In vitro selection of DNA elements highly responsive to the human T-cell lymphotropic virus type I transcriptional activator, Tax. Mol Cell Biol. 1994 Jan;14(1):456–462. doi: 10.1128/mcb.14.1.456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Pozzatti R., Vogel J., Jay G. The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells. Mol Cell Biol. 1990 Jan;10(1):413–417. doi: 10.1128/mcb.10.1.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Reith W., Siegrist C. A., Durand B., Barras E., Mach B. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):554–558. doi: 10.1073/pnas.91.2.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Reith W., Steimle V., Durand B., Kobr M., Mach B. Regulation of MHC class II gene expression. Immunobiology. 1995 Jul;193(2-4):248–253. doi: 10.1016/S0171-2985(11)80550-4. [DOI] [PubMed] [Google Scholar]
  68. Sartoris S., Accolla R. S. Transcriptional regulation of MHC class II genes. Int J Clin Lab Res. 1995;25(2):71–78. doi: 10.1007/BF02592360. [DOI] [PubMed] [Google Scholar]
  69. Schmidt E. E., Schibler U. Cell size regulation, a mechanism that controls cellular RNA accumulation: consequences on regulation of the ubiquitous transcription factors Oct1 and NF-Y and the liver-enriched transcription factor DBP. J Cell Biol. 1995 Feb;128(4):467–483. doi: 10.1083/jcb.128.4.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Schreiber E., Matthias P., Müller M. M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 1989 Aug 11;17(15):6419–6419. doi: 10.1093/nar/17.15.6419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Scott M. L., Fujita T., Liou H. C., Nolan G. P., Baltimore D. The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. Genes Dev. 1993 Jul;7(7A):1266–1276. doi: 10.1101/gad.7.7a.1266. [DOI] [PubMed] [Google Scholar]
  72. Shirabe S., Nakamura T., Tsujihata M., Nagataki S., Seiki M., Yoshida M. Retrovirus from human T-cell leukemia virus type I-associated myelopathy is the same strain as a prototype human T-cell leukemia virus type I. Arch Neurol. 1990 Nov;47(11):1258–1260. doi: 10.1001/archneur.1990.00530110120029. [DOI] [PubMed] [Google Scholar]
  73. Sinha S., Kim I. S., Sohn K. Y., de Crombrugghe B., Maity S. N. Three classes of mutations in the A subunit of the CCAAT-binding factor CBF delineate functional domains involved in the three-step assembly of the CBF-DNA complex. Mol Cell Biol. 1996 Jan;16(1):328–337. doi: 10.1128/mcb.16.1.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Sinha S., Maity S. N., Lu J., de Crombrugghe B. Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1624–1628. doi: 10.1073/pnas.92.5.1624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Smith M. R., Greene W. C. Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 1990 Nov;4(11):1875–1885. doi: 10.1101/gad.4.11.1875. [DOI] [PubMed] [Google Scholar]
  76. Smith M. R., Greene W. C. Type I human T cell leukemia virus tax protein transforms rat fibroblasts through the cyclic adenosine monophosphate response element binding protein/activating transcription factor pathway. J Clin Invest. 1991 Sep;88(3):1038–1042. doi: 10.1172/JCI115364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Stone D. M., Hof A. J., Davis W. C. Up-regulation of IL-2 receptor alpha and MHC class II expression on lymphocyte subpopulations from bovine leukemia virus infected lymphocytotic cows. Vet Immunol Immunopathol. 1995 Sep;48(1-2):65–76. doi: 10.1016/0165-2427(95)05423-4. [DOI] [PubMed] [Google Scholar]
  78. Sun S. C., Ganchi P. A., Ballard D. W., Greene W. C. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science. 1993 Mar 26;259(5103):1912–1915. doi: 10.1126/science.8096091. [DOI] [PubMed] [Google Scholar]
  79. Suzuki T., Fujisawa J. I., Toita M., Yoshida M. The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):610–614. doi: 10.1073/pnas.90.2.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Tanaka A., Takahashi C., Yamaoka S., Nosaka T., Maki M., Hatanaka M. Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc Natl Acad Sci U S A. 1990 Feb;87(3):1071–1075. doi: 10.1073/pnas.87.3.1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Wagner S., Green M. R. HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science. 1993 Oct 15;262(5132):395–399. doi: 10.1126/science.8211160. [DOI] [PubMed] [Google Scholar]
  82. Wright K. L., Vilen B. J., Itoh-Lindstrom Y., Moore T. L., Li G., Criscitiello M., Cogswell P., Clarke J. B., Ting J. P. CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors. EMBO J. 1994 Sep 1;13(17):4042–4053. doi: 10.1002/j.1460-2075.1994.tb06721.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Yamaoka S., Inoue H., Sakurai M., Sugiyama T., Hazama M., Yamada T., Hatanaka M. Constitutive activation of NF-kappa B is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J. 1996 Feb 15;15(4):873–887. [PMC free article] [PubMed] [Google Scholar]
  84. Yoshida M. HTLV-1 Tax: regulation of gene expression and disease. Trends Microbiol. 1993 Jul;1(4):131–135. doi: 10.1016/0966-842x(93)90127-d. [DOI] [PubMed] [Google Scholar]
  85. Yoshida M., Osame M., Kawai H., Toita M., Kuwasaki N., Nishida Y., Hiraki Y., Takahashi K., Nomura K., Sonoda S. Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann Neurol. 1989 Sep;26(3):331–335. doi: 10.1002/ana.410260304. [DOI] [PubMed] [Google Scholar]
  86. Yoshida M., Osame M., Usuku K., Matsumoto M., Igata A. Viruses detected in HTLV-I-associated myelopathy and adult T-cell leukaemia are identical on DNA blotting. Lancet. 1987 May 9;1(8541):1085–1086. doi: 10.1016/s0140-6736(87)90506-x. [DOI] [PubMed] [Google Scholar]
  87. Zeleznik-Le N. J., Azizkhan J. C., Ting J. P. Affinity-purified CCAAT-box-binding protein (YEBP) functionally regulates expression of a human class II major histocompatibility complex gene and the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1873–1877. doi: 10.1073/pnas.88.5.1873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Zervos A. S., Gyuris J., Brent R. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell. 1993 Jan 29;72(2):223–232. doi: 10.1016/0092-8674(93)90662-a. [DOI] [PubMed] [Google Scholar]
  89. Zhao L. J., Giam C. Z. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7070–7074. doi: 10.1073/pnas.89.15.7070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Zhao T. M., Robinson M. A., Bowers F. S., Kindt T. J. Characterization of an infectious molecular clone of human T-cell leukemia virus type I. J Virol. 1995 Apr;69(4):2024–2030. doi: 10.1128/jvi.69.4.2024-2030.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Zwicker J., Gross C., Lucibello F. C., Truss M., Ehlert F., Engeland K., Müller R. Cell cycle regulation of cdc25C transcription is mediated by the periodic repression of the glutamine-rich activators NF-Y and Sp1. Nucleic Acids Res. 1995 Oct 11;23(19):3822–3830. doi: 10.1093/nar/23.19.3822. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular and Cellular Biology are provided here courtesy of Taylor & Francis

RESOURCES